Age-related care often starts at the prescription level. A provider may need a specific dose, route, or formulation that commercial medications do not supply for a patient’s care plan.
Prescription required. All compounded medications are prepared based on a valid prescription from a licensed healthcare provider. Compounded formulations are not FDA-approved.
Compounded Preparations
6mg/mL, 7.5mL multi-dose vial
15-50-100mg/mL, 30mL vial
15-50-50-5mg/mL, 10 or 30mL vials
100mcg/0.1mL
0.9mg/mL, 0.22, 0.33mL vials
Compounded liraglutide is not FDA-approved. It is prepared based on an individual patient’s prescription. Providers are responsible for determining whether this formulation is clinically appropriate for their patient.
100mcg/0.1mL bottle
0.9mg/mL, 0.22, 0.33mL vials
200mg/mL, 30mL vial
6mg/mL, 7.5mL multi-dose vial
Rapamycin Capsule
customizable dose
PT-141 (Bremelanotide) Nasal Spray
10mg/mL, 10mL, 15mL, 20mL bottle
Oxytocin Nasal Spray
customizable dose
Oxytocin Sublingual
customizable dose
Coming Soon
Compounded liraglutide is not FDA-approved. It is prepared based on an individual patient’s prescription. Providers are responsible for determining whether this formulation is clinically appropriate for their patient.
NAD+ 100mg/mL, 10mL vial
Low Dose Naltrexone (LDN)
1.5mg, 3mg, 4.5mg Capsules
Methylene Blue
5mg, 10mg, 25mg, 50mg Capsules
Compounded liraglutide is not FDA-approved. It is prepared based on an individual patient’s prescription. Providers are responsible for determining whether this formulation is clinically appropriate for their patient.
Female Facial Cream
CoQ10 1%, Lipoic Acid 5%, Vitamin C Ester 5%, DMAE 3%, Estriol 0.3%
Male Facial Cream
CoQ10 1%, Lipoic Acid 5%, Vitamin C Ester 5%, DMAE 3%,
Skin Elasticity Support Cream
Tretinoin 0.1% PracaSil-Plus Gel
Skin Texture Support Cream
Aloe Vera 0.5% PracaSil-Plus Gel
Compounded liraglutide is not FDA-approved. It is prepared based on an individual patient’s prescription. Providers are responsible for determining whether this formulation is clinically appropriate for their patient.
Minoxidil 20% Solution
30mL, 60mL spray
Finasteride 0.1%, Minoxidil 7% Solution
30mL, 60mL spray
Compounded liraglutide is not FDA-approved. It is prepared based on an individual patient’s prescription. Providers are responsible for determining whether this formulation is clinically appropriate for their patient.
*Compounded medications are prepared based on a healthcare provider’s prescription to meet individual patient needs. These medications are not FDA-approved, and no claims are made regarding their safety, efficacy, or quality. While we offer compounded medications tailored to individual needs, we also have commercially available drugs for patients when appropriate. All doses listed are common doses; customized medication strengths are also available as prescribed by a licensed provider.
Understanding the Difference
Licensed providers send the prescription first. That order controls the medication, dose, and route MediVera Compounding Pharmacy prepares. At the PCAB-accredited Troy, Michigan facility, pharmacists work under USP 795, USP 797, and USP 800. Before release, independent lab testing adds a separate quality check.
Longevity Compound Categories Providers May Prescribe:
MediVera’s longevity compounding services include prescription-based options across common wellness and age-management protocols.
Every compound requires a valid prescription. MediVera does not diagnose conditions or recommend treatments. The pharmacy fills prescriptions written by a patient’s healthcare provider. Compounded medications are not reviewed by the FDA for safety or effectiveness.
Including injectable and nasal spray preparations for provider-directed protocols involving cellular energy metabolism
For prescription protocols involving age-related wellness and physiologic function
For care plans involving oxidative stress response
For providers managing age-related hormone changes in their patients
MediVera is a PCAB-accredited 503A compounding pharmacy, accreditation held by fewer than 1% of pharmacies in the United States.
Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a licensed pharmacist or physician may compound a drug product for an identified individual patient based on a valid prescription from a licensed practitioner.
“What our patients
and providers say”
Accreditations & Certifications
Dual accreditation held by fewer than 1% of U.S. compounding pharmacies.